As of March 2026 Enliven Therapeutics has a market cap of A$2.49 Billion. This makes Enliven Therapeutics the world's 4870th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 11th, 2026 the market cap of Enliven Therapeutics was reported to be: